本页面由Tiger Trade Technology Pte. Ltd.提供服务

Revolution Medicines, Inc.

78.51
+2.553.36%
成交量:159.94万
成交额:1.24亿
市值:151.78亿
市盈率:-15.12
高:79.10
开:77.56
低:76.45
收:75.96
52周最高:81.49
52周最低:29.17
股本:1.93亿
流通股本:1.65亿
量比:0.51
换手率:0.97%
股息:- -
股息率:- -
每股收益(TTM):-5.1931
每股收益(LYR):-3.5776
净资产收益率:-60.76%
总资产收益率:-32.29%
市净率:9.50
市盈率(LYR):-21.95

数据加载中...

2025/06/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/08

重要事件披露

Form 8-K - Current report
2025/03/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/26

重要事件披露

Form 8-K - Current report
2025/02/26

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/26

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/01/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/05

重要事件披露

Form 8-K - Current report